Additionally, a pilot analysis was performed on a small subset of STS tumor samples using the same strategy to gain preliminary insights into tumor-infiltrating lymphocytes (TIL, CD3+ and/or CD56+ cells). The gene discussed is NCAM1; the disease is neoplasm.